Skip to content

Alto Neuroscience ANRO Interest coverage

Interest coverage at other companies

Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
2.5×-5.9×
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
-13.1×-0.2×
Alkermes logo
AlkermesALKS
5.8×-17.8×
Medtronic logo
MedtronicMDT
9.1×+0.9×
Arrowhead Research logo
Arrowhead ResearchARWR
-2.4×+0.9×
Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
-14.9×-22.4×

Other financials

Income statement

See full
Operating income-$27.1M-73.1%
Net income-$26.2M-73.0%
EPS (diluted)-$0.80-42.9%

Balance sheet

See full
Cash & equivalents$264.3M+63.9%
Total debt$20.9M-17.2%
Total equity$243.4M+75.0%
Total assets$276.3M+60.7%

Cash flow

See full
Operating cash flow-$27.1M-63.6%
CapEx$556.0K+2,217%
Free cash flow-$27.6M-66.7%

Valuation

See full
Market cap$874.19M+1,358%
Enterprise value$630.81M-958%

Returns & leverage

See full
Return on equity-38.9%+0.9pp
Debt / equity0.1×-0.1×
Current ratio20.5×-2.0×

Where this comes from

Calculated from Alto Neuroscience’s reported figures.

Based on trailing twelve months.

The official record: Alto Neuroscience’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alto Neuroscience's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alto Neuroscience's interest coverage?
Alto Neuroscience (ANRO) reported interest coverage of -32.2× in Q1 2026.
How has Alto Neuroscience's interest coverage changed year-over-year?
Alto Neuroscience's interest coverage increased by 25.0% year-over-year, from -43× to -32.2×.
What is the long-term trend for Alto Neuroscience's interest coverage?
Over 2 years (2023 to 2025), Alto Neuroscience's interest coverage has grown at a -1.3% compound annual growth rate (CAGR), from -27.6× to -26.9×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.